Search

everythinglearnresearchcommunity

for

Search:↓

Patients with mycosis fungoides have a higher risk of heart disease.

The case shows how hard it is to tell apart Multiple Autoimmune Syndrome from other similar autoimmune conditions, but correct diagnosis is key for treatment to work.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Recognizing LET and AITD can help diagnose SLE early for better treatment.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.

A girl with lupus and trisomy X has a higher risk of bone problems like avascular necrosis and osteoporosis.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Most patients with Systemic Lupus Erythematosus experience fatigue, skin issues, and joint pain.

Early diagnosis and treatment of systemic-onset juvenile idiopathic arthritis are crucial for improvement.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Absence of skin rash and low complement C3 levels increase the risk of lupus nephritis.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

New tools were created to help lupus patients report their symptoms and impacts more accurately.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Anti-SSB antibodies are useful for diagnosing systemic lupus erythematosus and are linked to specific symptoms.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

A man with four autoimmune diseases suggests a new category for multiple autoimmune syndrome.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

RDW can be a useful marker for inflammation in alopecia areata patients.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.